Includes: Base Screen Panel – common basic drugs (non inclusive list) • Fluoxetine •… and 1 more item

The Virginia Department of Health awarded contract PO05463426 to NMS Labs on September 8, 2026, with a cumulative value of $2,916.00. The contract encompasses laboratory testing services for forensic analysis, with deliverables directed to Jennifer Starkey. The primary line item consists of nine Base Screen Panel tests focusing on common basic drug detection, including screening for fluoxetine, chlorpheniramine, propoxyphene, mirtazapine, sertraline, diltiazem, bupropion, ketamine, fluvoxamine, doxylamine, brompheniramine, doxepin, paroxetine, and trazodone, at a unit price of $292 per test.

The contract also includes three Electrolytes and Glucose Panel tests on vitreous fluid for forensic purposes at $96 per test. These laboratory services support the Department of Health's forensic analysis capabilities, enabling toxicological screening and metabolic assessment of biological specimens in accordance with investigative protocols. The contract specifications reflect standard forensic pathology testing requirements for comprehensive drug and metabolic panel analysis.